<DOC>
	<DOCNO>NCT02672280</DOCNO>
	<brief_summary>The purpose present study evaluate safety exploratory efficacy medical collagen membrane umbilical cord derive mesenchymal stem cell treatment patient skin defect .</brief_summary>
	<brief_title>Safety Exploratory Efficacy Study Collagen Membrane With Mesenchymal Stem Cells Treatment Skin Defects</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Age 18 70 , borh gender . Patient able willing sign inform consent comply study procedure . Women childbearing potential must use birth control pill , barrier abstinence negative pregnancy test . Deep partial full thickness skin defect least 9 cm2 require surgical wound coverage due : burn injury , diabetic foot ulcer wound cause mechanical damage iatrogenic injury . Patient refusal . Patient documented history allergy sensitivity animal product use preparation skin substitute . These product include bovine blood , bovine collagen , bovine collagenase . Patient documented history allergy sensitivity antimicrobial reagent use preparation application skin substitute include irrigation solution use grafting . Patient current diagnosis invasive burn wound infection unexcised burn wound . Patient tunnel sinus tract completely debrided . Serious primary disease liver , kidney hematopoietic system , Abnormal liver function ( glutamicpyruvic transaminase ( ALT ) , glutamicoxalacetic transaminase ( AST ) 2 time higher normal value ) , creatinine ( Cr ) high upper limit normal value . Other clinical trial participant within 3 month . A random blood sugar read &gt; /=450 mg/dL . Investigators judge condition suitable inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>